The Drug Enforcement Administration (DEA) recently issued an announcement concerning the transfer of controlled substance prescriptions for initial filling. This change, effective August 28, gives patients the ability to request their pharmacy transfer their electronic prescription to another pharmacy without the need to initiate the request via their practitioner.
While the change is not mandatory, it offers potential benefits for both pharmacies and patients, such as increasing flexibility and medication access. However, it’s important to note that implementing this change would necessitate a mini-audit for certification purposes.
Pharmacies willing to adopt the change must ensure they are equipped to meet the revised guidelines and can successfully navigate the mini-audit process. This ensures adherence to DEA regulations and fosters a safe and efficient prescription transfer process.
If your company develops pharmacy software solutions and is considering implementing this change, invite you to book a free consultation with our EPCS experts.